COVID-19 Hospitalizations Surge 40% in Two Weeks Amid Early Winter Virus Concerns
Experts warn of potential winter chaos as COVID-19 and flu cases rise, prompting calls for vaccination.
Hospital admissions in the UK due to COVID-19 have increased by over 40% in the past two weeks, with a corresponding rise in deaths. Recent data indicates that approximately 2.46 out of every 100,000 people are being hospitalized weekly with the virus, a significant jump from 1.75 per 100,000 a fortnight prior. The number of confirmed COVID-19 cases in October has already reached 3,942, suggesting a monthly total likely to double September's figures. Last month saw 4,589 cases, a threefold increase from August.
Experts are expressing concern about the early rise of COVID-19 alongside influenza, warning of potential strain on the National Health Service (NHS) during the upcoming winter. This comes after the NHS experienced its busiest summer on record. Deaths attributed to COVID-19 also saw a substantial increase, rising by 46.4% in the week leading up to October 2, with the total number of fatalities reaching 41.
Individuals aged 85 and over remain the most vulnerable demographic, with nearly 27 admissions per 100,000 population. This group also has the highest positivity rate for COVID-19, at approximately 13.5%, compared to the overall average of 8.8% across all age groups. Regionally, the West Midlands is experiencing the highest admission rates, with around 3.55 people per 100,000 requiring hospital treatment for the virus, while the South West has the lowest rate at approximately 1.5 per 100,000.
Professor Frankie Swords, the national medical director at NHS England, has noted "ominous early signs of winter pressure." The rise in flu cases has also been observed, with positive tests in September doubling compared to the previous year. Dr. Adam Finn, emeritus professor of paediatrics at the University of Bristol, highlighted that the noticeable increase in flu cases in September is unusually early, as significant rises are typically not seen until December. He suggests that reduced immunity due to COVID-19 lockdowns, during which social interactions were limited, may have contributed to this early surge, particularly affecting younger adults and children.
Despite these trends, current flu hospital admissions remained stable last week at 1.88 per 100,000 population, equating to about 1,070 weekly admissions. Health officials are urging eligible individuals to get vaccinated against both COVID-19 and flu. Dr. Jamie Lopez Bernal, consultant epidemiologist at the UK Health Security Agency (UKHSA), emphasized the importance of timely vaccination due to increasing flu levels and the possibility of an early flu season.
The primary COVID-19 strain circulating is known as XFG, or 'Stratus,' which has been prevalent in North America and Europe since late 2025. UKHSA officials state that these strains are closely related to those circulating for over a year and are not showing evidence of increased severity or faster spread. The autumn COVID-19 vaccine has been designed to provide protection against these strains. However, concerns remain regarding potential "drift" in flu strains, where genetic changes could reduce vaccine effectiveness. The UKHSA is monitoring for drifted AH1N1 viruses, which have been detected in Europe, including the UK. Vaccines were effective against drifted strains last year, but vigilance is required due to the unpredictability of dominant strains each winter.